摘要
目的观察拉米夫定治疗乙肝肝硬化的临床效果,提高临床治疗水平。方法 60例乙肝肝硬化患者,随机分为观察组(拉米夫定辅助治疗组)和对照组(常规治疗组)各30例,比较两组患者的治疗效果。结果两组患者疗效比较,差异具有统计学意义(P<0.01);两组患者治疗后各项指标比较,均有所改善,但观察组较对照组各项指标改善明显(P<0.01),具有统计学意义。结论拉米夫定辅助治疗乙肝肝硬化效果理想,值得临床推广使用。
Objective To observe the lamivudine treatment of hepatitis B cirrhosis effects and improve the level of clinical treatment. Methods 60 patients with hepatitis B Cirrhosis were randomly divided into two groups （larnivudine secondary treatment group） and control group （conventional treatment group） of the 30 cases,compared two groups of treatment.Results The two groups were compared, the difference has the effect of statistical signifieance（P〈0.01）.Conclusion The adjuvant treatment of liver cirrhosis with lamivudine results are satisfactory, is worthy of clinical use.
出处
《湖南中医药大学学报》
CAS
2011年第8期46-47,共2页
Journal of Hunan University of Chinese Medicine
关键词
拉米夫定
肝硬化
乙肝
Lamivudine
Cirrhosis
Hepatitis B
